PROS1 and infection: These findings further support the conviction that a prime-boost regimen with the ancestral SARS-CoV-2 S (but not natural infection alone) or hybrid immunity can elicit an antibody response (even if sub-optimal) against the B.1.1.529 lineage, the extent and potency of which seems to increase with the number of S-protein exposures.